Blood biomarkers and Ki-67 proliferation marker in breast cancer

Blood biomarkers and Ki-67 proliferation marker in breast cancer

Metastasis is the leading cause of death in patients with breast cancer (BC). It is known that the lesion of regional lymph nodes by tumor cells is more common in tumors with higher proliferative activity. Moreover, there is literature evidence on effects of cytokines and proteins upon the migration...

Full description

Bibliographic Details
Main Authors:	A. A. Studenikina, E. S. Mikhaylova, S. A. Arkhipov, N. A. Varaksin, A. V. Proskura, A. I. Autenshlyus
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-04-01
Series:	Медицинская иммунология
Subjects:	cytokines proteins ki-67 proliferation metastasis breast cancer
Online Access:	https://www.mimmun.ru/mimmun/article/view/2570

Similar Items

The expression of Ki-67 marker in the hydatidiform mole
by: Ecaterina Carpenco, et al.
Published: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
by: Fatima S. Al-Sarraf, et al.
Published: (2015-07-01)

Ki-67 protein: a proliferation index in breast cancer
by: Shervin Kheirandish, et al.
Published: (2015-10-01)

Study of the cell proliferation index (Ki67) in inflammatory odontogenic cysts
by: Mamadou Diatta, et al.
Published: (2023-09-01)

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
by: Rashi GARG, et al.
Published: (2019-01-01)

piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
by: Rokshana Stephny Geread, et al.
Published: (2020-12-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations
by: Brian S. Finkelman, et al.
Published: (2023-01-01)

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
by: Deligonul Adem, et al.
Published: (2021-04-01)

Detection of Ki67 Hot-Spots of Invasive Breast Cancer Based on Convolutional Neural Networks Applied to Mutual Information of H&E and Ki67 Whole Slide Images
by: Zaneta Swiderska-Chadaj, et al.
Published: (2020-11-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
by: Christina Marouda, et al.
Published: (2024-01-01)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
by: Matthew G. Davey, et al.
Published: (2021-09-01)

Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01)

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer
by: Hongxiao Zhang, et al.
Published: (2024-01-01)

Expression of Ki 67 and P53 immunohistochemical markers in central nervous system astrocytoma
by: Mahmood Sh. Mahmood, et al.
Published: (2015-01-01)

Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer
by: Snežana Đokić, et al.
Published: (2024-04-01)

Does a 40% Cut-off Point for Ki-67 Expression Have a Role in Identifying the Development of Distant Metastasis Within 2 Years in Locally Advanced Triple Negative Breast Cancer Patients?
by: Kelvin Setiawan, et al.
Published: (2023-10-01)

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
by: Mallikarjuna Siraganahalli Eshwaraiah, et al.
Published: (2023-06-01)

The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients
by: Ma Q, et al.
Published: (2024-03-01)

The clinical value of mismatch repair protein combined with serum tumor markers and Ki-67 proliferation index in the prognostic evaluation of colorectal cancer
by: CHEN Xi, ZENG Xiaoying, CHEN Jiayan, LIU Fei, TANG Xi
Published: (2022-03-01)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
by: Annkathrin Estaller, et al.
Published: (2022-05-01)

Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells
by: DONG Jun, CUI Fengming, LIU Jun
Published: (2023-05-01)

The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors
by: YongYan Cui, et al.
Published: (2020-03-01)

Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia .
by: Subh S. AL- Mudallal, et al.
Published: (2013-01-01)

Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors
by: Gül Kanyılmaz, et al.
Published: (2019-10-01)

Digital image analysis of immunohistochemistry KI-67 using QuPath software in breast cancer
by: Hermin Aminah Usman, et al.
Published: (2021-04-01)

Ki-67 is expressed in multiplying forms of Schistosoma mansoni, but not in snail host tissues
by: Tânia Maria Correia Silva, et al.
Published: (2007-08-01)

Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study
by: K A Kamala, et al.
Published: (2022-01-01)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
by: Ceren Boyaci, et al.
Published: (2021-10-01)

Tp53 Expression and Ki-67 Proliferation Index in Surface Epithelial-Stromal Tumors of the Ovary and Their Relationship with the Histopathological Prognostic Parameters
by: Sevgiye Kaçar Özkara, et al.
Published: (2011-11-01)

Correlation of Peritumoral Brain Edema with Morphological Characteristics and Ki67 Proliferative Index in Resected Intracranial Meningiomas
by: Hakija Bečulić, et al.
Published: (2019-01-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
by: Payal Doctor, et al.
Published: (2023-04-01)

Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer
by: Radhika Arora, et al.
Published: (2023-12-01)

Ki-67 Antigen; A Valuable Prognostic Biomarker for Chronic Lymphocytic Leukemia
by: Valiollah Mehrzad, et al.
Published: (2022-01-01)

Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies
by: Stefan G.C. Mestrum, et al.
Published: (2023-08-01)

Comparative study of Ki67 protein expression in oral lichen planus and leukoplakia
by: Yu. V. Molochkova, et al.
Published: (2018-12-01)

Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma
by: Amol Ramchandra GADBAIL, et al.
Published: (2021-03-01)

EXPRESSION OF OCT-4, P53, P16 AND KI-67, WITH HPV ASSOCIATED PRECANCER AND CANCER OF THE CERVIX
by: E A Kogan, et al.
Published: (2016-03-01)

PIK3CA, KI67, Estrogen (ER) and Progesterone Receptors (PR) Expression Pattern of in HER2 Positive Breast Cancers
by: Samuel I. Ogenyi, et al.
Published: (2022-02-01)

Use of Novel Open-Source Deep Learning Platform for Quantification of Ki-67 in Neuroendocrine Tumors – Analytical Validation
by: Zehra T, et al.
Published: (2023-12-01)